What Enbridge's C$2.6 Billion Share Sale Actually Buys

Enbridge, the Calgary pipeline giant, is selling a large block of new common shares to a syndicate of investment banks in what's known in the market as a bought deal — a single, fast placement where the underwriters buy the whole offering up front and take the risk of reselling it. The immediate instinct for any holder is dilution: how much of their ownership and per-share cash flow is being handed to a bank that wants to flip the shares quickly. That instinct is worth taking seriously, because the payout is the whole reason most people own this stock. The dividend yields about 5.5%, and Enbridge has raised it for 31 straight years. Any move that spreads the dividend across more shares matters.

So let's size the dilution before judging it. The offering is roughly C$2.6 billion against a company with about 2.2 billion shares outstanding and a market value north of US$100 billion. Working through the arithmetic, new shares would amount to something close to 1.5–2% of the float. That's real — it trims what each existing share collects — but it is not the kind of raise that signals distress. Issuing 2% of the company to keep the balance sheet healthy is a different event than issuing equity because debt is unavailable.

The structure underscores that this is a deliberate financing decision, not an emergency. In Enbridge's most recent comparable placement, a C$4.0 billion bought deal in September 2023, the banks took roughly 89.5 million shares at a set price with the option to sell up to 15% more if demand ran hot. Compressing a multi-day roadshow into a single priced block lets a company lock in financing fast, and the institutional buyers who pay slightly above the discount get the shares immediately. Enbridge has used the mechanism before, including to fund acquisitions.

The more interesting question is why a company with a rich stock price and a fee-based cash-flow machine would rather sell shares than keep borrowing. The answer sits on the balance sheet. Enbridge ended 2025 at 4.8 times debt to EBITDA, near the top of its own stated 4.5–5.0 times target band. Selling equity trims leverage without adding debt, and a company trading at a premium to its peers is issuing stock precisely when each dollar of dilution buys the most balance-sheet relief. Issuers prefer to sell high.

Then there's the growth program the cash is likely to back. Enbridge carries a secured project backlog of about C$39 billion and expected to place roughly C$8 billion of projects into service in 2026, with annual investment capacity of C$10–11 billion. A raise that reduces the need to lever up for that capex, or pays down a slice of a net-debt load in the tens of billions, is a capital-allocation choice wrapped around a carefully managed credit profile.

The coverage test confirms the story. Midstream cash flows are better measured by distributable cash flow than by reported net income, and on that basis Enbridge generated about C$12.5 billion of DCF in 2025 — its 20th straight year of hitting or beating guidance — with 2026 guidance of C$5.70–6.10 a share against a dividend of C$3.88. That works out to roughly 1.5 times coverage. The dividend is not at risk here. This raise is funding growth and balance-sheet headroom, not papering over a shortfall.

That leaves the valuation caveat, and it's the part worth holding onto. Enbridge trades at roughly 15–16 times EV/EBITDA, above Kinder Morgan's low-teens multiple and TC Energy's mid-teens, even with a much richer Williams above it. The stock is not cheap. So the honest reading of a C$2.6 billion equity tap is not "survival" and not "distress" — it's a modest dilution tax on a fee-based cash-flow machine that keeps its leverage inside the guided band while it funds a huge contracted backlog. The survival hurdle clears easily. The live question is whether those contracted growth dollars will justify a premium multiple that the market is already paying for. That is the condition that would change the story.